
- /
- Supported exchanges
- / US
- / LABFF.PINK
Laboratorios Farmaceuticos Rovi S.A (LABFF PINK) stock market data APIs
Laboratorios Farmaceuticos Rovi S.A Financial Data Overview
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, aseptic filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Its products are used for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Laboratorios Farmaceuticos Rovi S.A data using free add-ons & libraries
Get Laboratorios Farmaceuticos Rovi S.A Fundamental Data
Laboratorios Farmaceuticos Rovi S.A Fundamental data includes:
- Net Revenue: 767 M
- EBITDA: 204 M
- Earnings Per Share: 3
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-06
- EPS/Forecast: NaN
Get Laboratorios Farmaceuticos Rovi S.A End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Laboratorios Farmaceuticos Rovi S.A News

Global Market Insights Three Stocks Possibly Trading Below Estimated Value
As global markets recently celebrated record highs, driven by easing geopolitical tensions and positive trade developments, investors are keenly observing opportunities amidst fluctuating economic ind...


European Stocks That May Be Trading Below Estimated Value In July 2025
As the European markets show signs of recovery, with the STOXX Europe 600 Index climbing 1.32% and Germany's DAX up by nearly 3%, investor optimism is bolstered by easing geopolitical tensions and pot...

European Stocks Priced Below Estimated Value In June 2025
As European markets face challenges with the pan-European STOXX Europe 600 Index ending 1.54% lower amid concerns over Middle East tensions, investors are keenly observing opportunities in stocks that...

European Market: BFF Bank And 2 Other Stocks Trading At Estimated Discounts
As the European market navigates through a period of heightened global uncertainty, with indices such as the STOXX Europe 600 reflecting concerns over geopolitical tensions, investors are increasingly...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.